Palisade Bio (PALI) Amortizatization of Intangibles (2020 - 2021)
Palisade Bio (PALI) reported Amortizatization of Intangibles of $5000.0 for Q4 2021, down 97.06% year-over-year from $170000.0 in Q4 2020, and down 96.18% on a QoQ basis from $131000.0 in Q3 2021.
Palisade Bio (PALI) has 2 years of Amortizatization of Intangibles data on file, last reported at $5000.0 in Q4 2021.
- Quarterly Amortizatization of Intangibles fell 97.06% year-over-year to $5000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $5000.0 (down 99.8% YoY) and the FY2021 annual result came in at $2.3 million, up 1057.92% from the prior year.
- Amortizatization of Intangibles retreated to $5000.0 in Q4 2021 per PALI's latest filing, from $131000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.6 million in Q1 2021 and bottomed at $5000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 1.59 Mn |
| Mar 31, 2021 | 1.59 Mn |
| Dec 31, 2020 | 170,000.00 |
| Dec 31, 2020 | 170,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Sep 30, 2020 | 20,000.00 |